Consequently, the TGF-β/Smad signaling pathway plays crucial roles in the proliferation of carcinoma cells, regulation of cell cycle activity, and EMT, as well as other biological behaviors, and has emerged as an important therapeutic target in neoplasm treatment research. This evidence concerns the gene TGFB1 and neoplasm.